Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as doubleblind, placebo-controlled trials with respect to ABPM measurements

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1572261550188652288
  • NII Article ID
    10016904186
  • Data Source
    • CiNii Articles

Report a problem

Back to top